Subclinical Thyroid Disease and Mortality in the Elderly: A Retrospective Cohort Study Alon Grossman, MD, MHA, Avraham Weiss, MD, Nira Koren-Morag, PhD, Ilan Shimon, MD, Yichayaou Beloosesky, MD, Joseph Meyerovitch, MD The American Journal of Medicine Volume 129, Issue 4, Pages 423-430 (April 2016) DOI: 10.1016/j.amjmed.2015.11.027 Copyright © 2016 Elsevier Inc. Terms and Conditions
Figure 1 Flow chart for final cohort selection. ft4 = free T4; TSH = thyroid-stimulating hormone. The American Journal of Medicine 2016 129, 423-430DOI: (10.1016/j.amjmed.2015.11.027) Copyright © 2016 Elsevier Inc. Terms and Conditions
Figure 2 Kaplan-Meier survival curves by thyroid-stimulating hormone groups for the entire cohort. TSH = thyroid-stimulating hormone. The American Journal of Medicine 2016 129, 423-430DOI: (10.1016/j.amjmed.2015.11.027) Copyright © 2016 Elsevier Inc. Terms and Conditions
Figure 3 Kaplan-Meier curves for mortality stratified for thyroid-stimulating hormone values in individuals with subclinical hypothyroidism. TSH = thyroid-stimulating hormone. The American Journal of Medicine 2016 129, 423-430DOI: (10.1016/j.amjmed.2015.11.027) Copyright © 2016 Elsevier Inc. Terms and Conditions